UBE2C and neoplasm: In addition, high-level UBE2C expression also significantly correlated with established clinical and molecular markers for unfavourable tumour biology, including INSS stages, a high-risk tumour transcriptional profile defined by principal access method (PAM) analysis and unfavourable Shimada/INPC tumour histology (Fig. 6F).